Why Some CLL Patients Stop Responding to Venetoclax Why Some CLL Patients Stop Responding to Venetoclax

Why some patients stop responding to venetoclax may be explained by acquired resistance conferred by a Gly101Val mutation in BCL2. But there are likely other mechanisms.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news